Back

Risk factors for first and recurrent ICD therapy in primary and secondary prevention patients with an implantable cardioverter defibrillator

27 August 2023 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Novel approaches for predicting and treating ventricular arrhythmias Risk Factors and Risk Assessment ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Soeren Zoega Diederichsen

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

8 More presentations in this session

Presentation thumbnail
Incidence of sustained ventricular tachyarrhythmias in patients with non-ischemic cardiomyopathy in a multicenter multinational WCD cohort
Doctor J. Erath (Frankfurt, DE)
Abstract Slides Video
Presentation thumbnail
Using the 3D architecture of scar to predict life-threatening ventricular arrhythmias, still a long way to go
Doctor R. Amador (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Integration of electro-anatomical maps in the planning phase of stereotactic arrhythmia radioablation for refractory ventricular tachycardia
Doctor C. Teres (Lausanne, CH)
Abstract Slides Video
Presentation thumbnail
Catheter ablation of ventricular arrhythmias in arrhythmogenic cardiomyopathy - comparison of different approaches and results of genetic testing
Doctor A. Rafaj (Prague, CZ)
Abstract Slides Video
Presentation thumbnail
A valuable electrophysiological insight to distinguish right from left outflow tract ventricular arrhythmia -local activation time in the anterior intraventricular vein and distal great cardiac vein-
Doctor J. Doi (Tsuchiura, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Novel approaches for predicting and treating ventricular arrhythmias

The Event

Event poster

ESC Congress 2023

27 August 2023 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Marked differences in ICD therapy frequencies between phenotypes
thumbnail
Congress Presentation
Long-term follow-up in patients with hypertrophic cardiomyopathy after defibrillator implantation: analysis of appropriate and inappropriate therapy
thumbnail
Congress Session
Recent advances in implantable cardioverter defibrillator therapy

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources